Immunoglobulins: Global Market Outlook

Publisher Name :
Date: 30-Mar-2023
No. of pages: 64

Report Scope:

The scope of this study encompasses the current and forecast markets for normal and hyper immunoglobulins. The report segments markets based on product type and route of administration. The report surveys the competitive landscape, market dynamics and current and developing technologies. The report also analyzes the impact of COVID-19 on the market.

In terms of geographical regions, the report analyzes the market across North America, Europe, Asia-Pacific and the rest of the world (RoW). Key regions such as the U.S., Canada, Europe (U.K., Italy, France and Germany), Asia-Pacific (China, India and Japan) are highlighted in the discussion.

The report also analyzes key companies and their recent developments, such as product launches, business expansions and collaborations.

Report Includes:

- A brief general outlook of the global market for immunoglobulins

- Analyses of the global market trends, with historic market revenue data (sales figures) for 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027

- Estimation of the actual market size and revenue forecast for the global immunoglobulins market in USD million terms, and corresponding market share analysis by product type, route of administration, and region

- In-depth information (facts and figures) concerning the major factors influencing the progress of this market (benefits, and industry-specific challenges) with respect to specific growth trends, upcoming technologies, current and future prospects in therapeutic treatments, and contributions to the overall market

- Identification of major stakeholders and analysis of the company competitive landscape based on their recent developments, financial performance, segmental revenues, and operational integration

- Company profiles of the market leading players

Summary:

The global immunoglobulins (IG) market was estimated to be $REDACTED billion in 2021. The immunoglobulins market is projected to grow at a compound annual growth rate (CAGR) of REDACTED% and is expected to reach $REDACTED billion by the end of 2027. Increasing demand for immunoglobulins in various treatments and an increase in blood donations are the key factors driving the growth of the current immunoglobulins market. However, increasing research on alternative therapies and high manufacturing and treatment costs associated with immunoglobulin products could hinder market growth. Apart from drivers and restraints, growing investments in plasma fractionation capacities and increasing research on new formulations and indications should create huge opportunities for vendors in the market.

In this report, the global immunoglobulins market has been segmented based on type, route of administration and geographical region. Based on type, the immunoglobulins market has been categorized into normal and hyperimmune globulins. Normal immunoglobulins currently dominate the market and were valued at $REDACTED billion in 2021. The normal immunoglobulins market is expected to grow at a CAGR of REDACTED% and reach $REDACTED billion by the end of 2027.

Based on the route of administration, the immunoglobulins market has been segmented into intravenous (IV), subcutaneous (SC) and others. Among all route segments, the SC segment is expected to grow at the highest CAGR, REDACTED%, during the forecast period.

The immunoglobulins market has been segmented into the following geographical regions: North America; Europe; Asia-Pacific; and Rest of the World (RoW). The North American region currently dominates the global immunoglobulins market. In 2021, this region's total revenue reached $REDACTED billion, accounting for about REDACTED% of the global market. Key growth factors in this region include the presence of large fractionation facilities and the increasing demand for immunoglobulins in treating various immunodeficiency disorders. The Asia-Pacific immunoglobulins market was valued at $REDACTED billion in 2021. The Asia-Pacific immunoglobulins market is projected to grow at a CAGR of REDACTED% and reach $REDACTED billion by the end of 2027. The key growth driver of this region's market is the growing domestic plasma fractionation companies in countries such as South Korea and India.

Takeda Pharmaceutical Company Limited., CSL Ltd., Grifols International SA and Kedrion SpA are major players in the immunoglobulins market.

Immunoglobulins: Global Market Outlook

Table of Contents
Chapter 1 Introduction
1.1 Market Snapshot
Chapter 2 Executive Summary
Chapter 3 Market Overview
3.1 Immunoglobulin G (IgG)
3.2 Immunoglobulin M (IgM)
3.3 Immunoglobulin A (IgA)
3.4 Immunoglobulin E (IgE)
3.5 Immunoglobulin D (IgD)
3.6 Immunoglobulins Mechanism of Action
3.7 Clinical Use of Immunoglobulins
3.7.1 Replacement Therapy with Immunoglobulins
3.7.2 Immunoglobulin Blood Tests
3.8 Market Dynamics
3.8.1 Market Drivers
3.8.2 Market Restraints
Chapter 4 Emerging Technologies/ Opportunities
4.1 Growing Investments in Plasma Fractionation Capacities
4.2 Increasing Research on New Formulations and Indications
4.3 Growing Opportunities in Emerging Nations
4.4 Adoption of Digital Initiatives
Chapter 5 Market Breakdown by Type, Route of Administration
5.1 Immunoglobulins Market, by Type
5.1.1 Normal Immune Globulins
5.1.2 Hyperimmune Globulins
5.1.3 Market Size and Forecast
5.2 Immunoglobulins Market, by Route of Administration
5.2.1 Intravenous (IV) Administration
5.2.2 Subcutaneous (SC) Administration
5.2.3 Others
5.2.4 Market Size and Forecast
5.3 Normal Immunoglobulins Market, by Application
5.3.1 Primary Immune Deficiency (PID)
5.3.2 Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
5.3.3 Secondary Immune Deficiency (SID)
5.3.4 Multifocal Motor Neuropathy (MMN)
5.3.5 Other Neurological Disorders
5.3.6 Other Applications
5.3.7 Market Size and Forecast
Chapter 6 Market Breakdown by Region
6.1 Global Immunoglobulins Market Size, by Region
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Rest of the World
Chapter 7 Competitive Landscape
7.1 Recent Key Developments
7.2 Product Launches
7.3 Mergers and Acquisitions
7.4 Business Expansions
7.5 Agreements and Collaborations
7.6 Clinical Trials Landscape
Chapter 8 COVID-19 Impact: Immunoglobulins Market
8.1 COVID-19 Impact on the Immunoglobulins Market
8.1.1 Convalescent Plasma (CP) Therapy and Hyperimmune Globulins for COVID-19 Treatment
Chapter 9 Company Profiles
ADMA BIOLOGICS INC.
BAXTER INTERNATIONAL
BIO PRODUCTS LABORATORY LTD.
CHINA BIOLOGIC PRODUCTS INC.
CSL LTD.
GRIFOLS INTERNATIONAL S.A.
INNOVATIVE RESEARCH
INTAS PHARMACEUTICALS LTD.
KEDRION SPA
LFB S.A.
OCTAPHARMA AG
SANQUIN
TAKEDA PHARMACEUTICAL COMPANY LIMITED.
Chapter 10 Project Scope and Methodology
10.1 Scope of Report
10.2 Methodology
10.3 Analyst's Credentials
10.4 BCC Custom Research
10.5 Related BCC Research Reports

List of Tables
Summary Table : Global Market for Immunoglobulins, by Region, Through 2027
Table 1 : Immunoglobulin Blood Tests to Diagnose Health Conditions
Table 2 : Global Market for Immunoglobulins, by Type, Through 2027
Table 3 : Comparison of Intravenous and Subcutaneous Immunoglobulins
Table 4 : Global Market for Immunoglobulins, by Route of Administration, Through 2027
Table 5 : Global Market for Normal Immunoglobulins, by Application, Through 2027
Table 6 : Global Market for Immunoglobulins, by Region, Through 2027
Table 7 : North American Market for Immunoglobulins, by Type, Through 2027
Table 8 : North American Market for Immunoglobulins, by Route of Administration, Through 2027
Table 9 : North American Market for Immunoglobulins, by Country, Through 2027
Table 10 : European Market for Immunoglobulins, by Type, Through 2027
Table 11 : European Market for Immunoglobulins, by Route of Administration, Through 2027
Table 12 : European Market for Immunoglobulins, by Country, Through 2027
Table 13 : Asia-Pacific Market for Immunoglobulins, by Type, Through 2027
Table 14 : Asia-Pacific Market for Immunoglobulins, by Route of Administration, Through 2027
Table 15 : Asia-Pacific Market for Immunoglobulins, by Country, Through 2027
Table 16 : RoW Market for Immunoglobulins, by Type, Through 2027
Table 17 : RoW Market for Immunoglobulins, by Route of Administration, Through 2027
Table 18 : Product Launches, by Key Competitors, 2020-2022
Table 19 : Mergers and Acquisitions of Key Competitors, 2020-2022
Table 20 : Business Expansion Activities, by Key Competitors, 2020-2022
Table 21 : Agreements and Collaborations Activities, by Key Competitors, 2020-2022
Table 22 : Clinical Trial Activities of Key Competitors on Immunoglobulin Products
Table 23 : ADMA Biologics Inc.: Product Portfolio
Table 24 : ADMA Biologics Inc.: Developments and Strategies, 2022
Table 25 : Bio Products Laboratory Ltd.: Product Portfolio
Table 26 : Bio Products Laboratory Ltd.: Developments and Strategies, 2022
Table 27 : China Biologic Products Inc.: Product Portfolio
Table 28 : China Biologic Products Inc.: Developments and Strategies, 2022
Table 29 : CSL Ltd.: Product Portfolio
Table 30 : CSL Ltd.: Developments and Strategies, 2022
Table 31 : Grifols International S.A.: Product Portfolio
Table 32 : Grifols International S.A.: Developments and Strategies, 2022
Table 33 : Kedrion SpA: Product Portfolio
Table 34 : Kedrion SpA: Developments and Strategies, 2022
Table 35 : LFB S.A.: Developments and Strategies, 2022
Table 36 : Octapharma AG: Product Portfolio
Table 37 : Octapharma AG: Developments and Strategies, 2022
Table 38 : Takeda Pharmaceutical Company Limited: Product Portfolio
Table 39 : Takeda Pharmaceutical Company Limited: Developments and Strategies, 2022

List of Figures
Summary Figure : Global Market Shares of Immunoglobulins, by Region, 2021
Figure 1 : Global Market Shares of Immunoglobulins, by Type, 2021
Figure 2 : Global Market Shares of Immunoglobulins, by Route of Administration, 2021
Figure 3 : Global Market Shares of Normal Immunoglobulins, by Application, 2021
Figure 4 : Global Immunoglobulins Market, by Region
Figure 5 : Global Market Shares of Immunoglobulins, by Region, 2021
Figure 6 : Global Market Shares of Immunoglobulins, by Region, 2027
Figure 7 : ADMA Biologics Inc.: Financials, 2020 and 2021
Figure 8 : ADMA Biologics Inc.: Revenue Share, by Segment, 2021
Figure 9 : ADMA Biologics Inc.: Revenue Share, by Region, 2021
Figure 10 : CSL Ltd.: Annual Revenue, 2019-2021
Figure 11 : CSL Ltd.: Revenue Share, by Region/Country, 2021
Figure 12 : Grifols International S.A.: Financials, 2019-2021
Figure 13 : Grifols International S.A.: Revenue Share, by Business Segment, 2021
Figure 14 : Grifols International S.A.: Revenue Share, by Region/Country, 2021
Figure 15 : Kedrion SpA: Financials, 2019-2021
Figure 16 : Kedrion SpA: Revenue Share, by Segment, 2021
Figure 17 : Kedrion SpA: Revenue Share, by Region, 2021
Figure 18 : Octapharma AG: Financials, 2019-2021
Figure 19 : Takeda Pharmaceutical Company Limited: Financials, 2020 and 2021
Figure 20 : Takeda Pharmaceutical Company Limited: Revenue Share, by Region, 2021
Figure 21 : Takeda Pharmaceutical Company Limited: Revenue Share, by Business Segment, 2021
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs